Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - SPECTRUM PHARMACEUTICALS INCsppi20191231ex322.htm
EX-31.2 - EXHIBIT 31.2 - SPECTRUM PHARMACEUTICALS INCsppi20191231ex312.htm
EX-31.1 - EXHIBIT 31.1 - SPECTRUM PHARMACEUTICALS INCsppi20191231ex311.htm
EX-23.1 - EXHIBIT 23.1 - SPECTRUM PHARMACEUTICALS INCa2019exhibit231.htm
EX-21.1 - EXHIBIT 21.1 - SPECTRUM PHARMACEUTICALS INClistofsubsidiariesex21.htm
EX-10.12 - EXHIBIT 10.12 - SPECTRUM PHARMACEUTICALS INCa2009esppasamendedandr.htm
EX-10.11 - EXHIBIT 10.11 - SPECTRUM PHARMACEUTICALS INCindemnityagmt2019ex1011.htm
EX-10.9 - EXHIBIT 10.9 - SPECTRUM PHARMACEUTICALS INCleaseamend8irvinecompany.htm
EX-10.8 - EXHIBIT 10.8 - SPECTRUM PHARMACEUTICALS INCleaseamend7irvinecompany.htm
EX-4.5 - EXHIBIT 4.5 - SPECTRUM PHARMACEUTICALS INCex45-descriptionofequi.htm
10-K - 10-K - SPECTRUM PHARMACEUTICALS INCsppi-201910xk.htm

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Spectrum Pharmaceuticals, Inc. (the “Company”), hereby certifies, to such officer’s knowledge, that:
(i) the accompanying Annual Report on Form 10-K of the Company for the year ended December 31, 2019 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: March 2, 2020
Joseph W. Turgeon
Chief Executive Officer and President
This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.